Jiax Semanal (Methotrexate Disodium)

Methotrexate blocks dihydrofolate reductase, an enzyme needed to recycle folate for DNA and RNA synthesis. By limiting folate availability, the drug reduces the proliferation of rapidly dividing cells such as activated immune cells and malignant tumor cells, producing immunosuppressive and antiproliferative effects.

The exact dose of Jiax Semanal is individualized by the prescribing clinician based on the specific indication, disease severity, patient weight, renal and hepatic function, and response to therapy. No universal dosing schedule is provided; the prescriber sets the appropriate regimen.

Methotrexate is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy because it can cause fetal malformations and loss. It is also excreted in breast milk, so breastfeeding is not recommended while taking the medication.

To request Jiax Semanal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methotrexate is often preferred for its oral formulation, extensive clinical experience, and cost‑effectiveness compared with biologic agents or newer small‑molecule drugs such as leflunomide. While biologics target specific cytokines, methotrexate has a broader mechanism affecting cell proliferation, which can be advantageous in certain disease patterns but may require more laboratory monitoring.

Jiax Semanal tablets should be stored at room temperature, below 25 °C, in their original blister pack or container. Protect the product from excess moisture, direct sunlight, and heat to maintain stability throughout its shelf life.

Jiax Semanal is taken orally as a tablet. Patients should swallow the tablet whole with a full glass of water, preferably on an empty stomach or as directed by the prescriber. Dosing frequency (weekly, bi‑weekly, etc.) is determined by the treating physician.

The most critical adverse events include severe liver toxicity (potential fibrosis or hepatitis), bone‑marrow suppression leading to anemia or neutropenia, pulmonary fibrosis, and life‑threatening infections due to immunosuppression. Regular laboratory monitoring helps detect these complications early.

Jiax Semanal is contraindicated in patients with known hypersensitivity to methotrexate, active severe liver disease, significant renal impairment, uncontrolled infections, and in anyone who is pregnant or planning pregnancy. Caution is also advised for patients with pre‑existing blood‑cell disorders.